Novartis AG vs Morgan Stanley
Confronto della capitalizzazione di mercato nel tempo
Novartis AG
$272.5B
Posizione #51
Morgan Stanley
$281.9B
Posizione #48
Capitalizzazione di mercato nel tempo
Momenti chiave
- Morgan Stanley ha superato Novartis AG entro il 1999
- Novartis AG ha superato Morgan Stanley entro il 2002
- Morgan Stanley ha superato Novartis AG entro il 2003
- Novartis AG ha superato Morgan Stanley entro il 2005
- Morgan Stanley ha superato Novartis AG entro il 2006
- Novartis AG ha superato Morgan Stanley entro il 2008
- Morgan Stanley ha superato Novartis AG entro il 2024
Confronto anno per anno
| Anno | Novartis AG | Morgan Stanley | Leader |
|---|---|---|---|
| 2026 | $272.5B | $281.9B | Morgan Stanley |
| 2025 | $227.3B | $277.0B | Morgan Stanley |
| 2024 | $177.6B | $190.8B | Morgan Stanley |
| 2023 | $163.8B | $136.6B | Novartis AG |
| 2022 | $146.3B | $119.9B | Novartis AG |
| 2021 | $134.5B | $133.7B | Novartis AG |
| 2020 | $134.7B | $91.2B | Novartis AG |
| 2019 | $142.4B | $66.0B | Novartis AG |
| 2018 | $110.8B | $49.8B | Novartis AG |
| 2017 | $104.0B | $64.4B | Novartis AG |
| 2016 | $89.6B | $50.9B | Novartis AG |
| 2015 | $100.4B | $37.4B | Novartis AG |
| 2014 | $103.4B | $44.9B | Novartis AG |
| 2013 | $76.6B | $35.9B | Novartis AG |
| 2012 | $59.2B | $21.7B | Novartis AG |
| 2011 | $52.5B | $17.0B | Novartis AG |
| 2010 | $51.1B | $30.3B | Novartis AG |
| 2009 | $50.7B | $32.7B | Novartis AG |
| 2008 | $44.5B | $17.3B | Novartis AG |
| 2007 | $50.6B | $55.7B | Morgan Stanley |
| 2006 | $55.9B | $69.8B | Morgan Stanley |
| 2005 | $53.9B | $47.9B | Novartis AG |
| 2004 | $43.8B | $45.9B | Morgan Stanley |
| 2003 | $42.0B | $47.0B | Morgan Stanley |
| 2002 | $36.9B | $31.8B | Novartis AG |
| 2001 | $43.1B | $43.6B | Morgan Stanley |
| 2000 | $50.7B | $60.8B | Morgan Stanley |
| 1999 | $40.7B | $54.2B | Morgan Stanley |
| 1998 | $46.3B | $26.7B | Novartis AG |
| 1997 | $40.1B | $22.0B | Novartis AG |
| 1996 | $24.5B | $12.2B | Novartis AG |
| 1995 | $16.9B | $8.5B | Novartis AG |